Fibrolamellar hepatocellular carcinoma (FLHCC) accounts for less than 1% of all primary liver cancers. Due to an absence of known risk factors, most individuals are diagnosed at advanced stages of disease. Subsequently, these tumors carry a 30%–50% mortality rate and a 33%–100% recurrence rate in those treated with curative intent. Here, we describe an incidental discovery of an FLHCC tumor in a young male patient, who following surgical resection has remained recurrence free for over 11 years. This exceptionally long recurrence‐free survival highlights the advantage of early‐stage detection, the benefit of complete tumor resection, and further underscores the importance of regular postresection cancer surveillance.
Townsend et al. (Thu,) studied this question.